Literature DB >> 12701885

Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterases.

Sultan Darvesh1, Ryan Walsh, Earl Martin.   

Abstract

1. Acetylcholinesterase (AChE, EC 3.1.1.7) and butyrylcholinesterase (BuChE, EC 3.1.1.8) are serine hydrolase enzymes that catalyze the hydrolysis of acetylcholine. 2. (-) Huperzine A is an inhibitor of AChE and is being considered for the treatment of Alzheimer's disease. 3. In addition to esterase activity, AChE and BuChE have intrinsic aryl acylamidase activity. 4. The function of aryl acylamidase is unknown but has been speculated to be important in Alzheimer pathology. 5. Kinetic effects of (-) huperzine A and (+/-) huperzine A on the aryl acylamidase activity of human cholinesterases were examined. 6. (-) Huperzine A inhibited the aryl acylamidase activities of both AChE and BuChE. 7. (+/-) Huperzine A inhibited this function in AChE but stimulated BuChE aryl acylamidase suggesting that the (+) enantiomer is a powerful activator of this enzyme activity. 8. The two huperzine enantiomers may prove to be useful tools to examine the function of aryl acylamidase activity, including its role in Alzheimer pathology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12701885     DOI: 10.1023/a:1022597102063

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  24 in total

Review 1.  On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis.

Authors:  R T Bartus
Journal:  Exp Neurol       Date:  2000-06       Impact factor: 5.330

Review 2.  Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.

Authors:  D L Bai; X C Tang; X C He
Journal:  Curr Med Chem       Date:  2000-03       Impact factor: 4.530

3.  Mechanism of inhibition of cholinesterases by huperzine A.

Authors:  Y Ashani; J O Peggins; B P Doctor
Journal:  Biochem Biophys Res Commun       Date:  1992-04-30       Impact factor: 3.575

Review 4.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

Review 5.  Cholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.

Authors:  W J Krall; J J Sramek; N R Cutler
Journal:  Ann Pharmacother       Date:  1999-04       Impact factor: 3.154

6.  Some cerebral proteins and enzyme systems in Alzheimer's presenile and senile dementia.

Authors:  W Op den Velde; F C Stam
Journal:  J Am Geriatr Soc       Date:  1976-01       Impact factor: 5.562

Review 7.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

8.  Potencies and stereoselectivities of enantiomers of huperzine A for inhibition of rat cortical acetylcholinesterase.

Authors:  M McKinney; J H Miller; F Yamada; W Tuckmantel; A P Kozikowski
Journal:  Eur J Pharmacol       Date:  1991-10-15       Impact factor: 4.432

9.  The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.

Authors:  N Ariel; A Ordentlich; D Barak; T Bino; B Velan; A Shafferman
Journal:  Biochem J       Date:  1998-10-01       Impact factor: 3.857

10.  The aryl acylamidases and their relationship to cholinesterases in human serum, erythrocyte and liver.

Authors:  S T George; A S Balasubramanian
Journal:  Eur J Biochem       Date:  1981-12
View more
  1 in total

1.  Aryl acylamidase activity on acetylcholinesterase is high during early chicken brain development.

Authors:  Rathanam Boopathy; Paul G Layer
Journal:  Protein J       Date:  2004-07       Impact factor: 2.371

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.